GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sopharma AD-Sofia (WAR:SPH) » Definitions » Net Change in Cash

Sopharma AD-Sofia (WAR:SPH) Net Change in Cash : zł21 Mil (TTM As of Jun. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Sopharma AD-Sofia Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Sopharma AD-Sofia's Net Change in Cash for the three months ended in Jun. 2024 was zł4 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Jun. 2024 was zł21 Mil.

Sopharma AD-Sofia Net Change in Cash Historical Data

The historical data trend for Sopharma AD-Sofia's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sopharma AD-Sofia Net Change in Cash Chart

Sopharma AD-Sofia Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Change in Cash
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.08 -4.87 27.56 -39.14 238.86

Sopharma AD-Sofia Quarterly Data
Jun19 Sep19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.80 0.95 244.18 -229.11 4.49

Sopharma AD-Sofia Net Change in Cash Calculation

Sopharma AD-Sofia's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=98.656+-137.693+277.892+0
=239

Sopharma AD-Sofia's Net Change in Cash for the quarter that ended in Jun. 2024

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=337.751+20.706+-353.963+0
=4

Net Change in Cash for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was zł21 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sopharma AD-Sofia Net Change in Cash Related Terms

Thank you for viewing the detailed overview of Sopharma AD-Sofia's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Sopharma AD-Sofia Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sopharma AD-Sofia (WAR:SPH) » Definitions » Net Change in Cash
Comparable Companies
XBUL:SFT MCK COR CAH ASX:SIG SHSE:601607 HSIC HKSE:01099 SHSE:600332 XSWX:GALE MIL:AMP NZSE:EBO TSE:7459 SHSE:600998 SHSE:600511 PDCO TSE:2784 TSE:9987 SHSE:600739 SHSE:600056
Traded in Other Exchanges
SFA:Bulgaria
Address
5 Lachezar Stanchev Street, Sopharma Business Towers, Building A, Floor 11, Sofia, BGR, 1756
Website
https://www.sopharmagroup.com
Sopharma AD-Sofia is a company engaged in the production of pharmaceutical products. Its principal activities include the production and trade of medicinal substances and finished drug forms; and research and development as well as engineering and implementation activities in the field of medicinal products. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company's segments are the Production of pharmaceutical products; Distribution of pharmaceutical products; and Others. It generates the majority of its revenue from the Distribution of pharmaceutical products.